Verification evidence is still being completed.
PDF / print export
Biosergen
Solna, Sweden
- Verified lead
- Tine Kold Olesen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Antifungal Drugs, Anti-Infectives, Invasive Fungal Infections, Clinical Development, and Biotech
- Review cycle
- May 2026
- Full address
- Fogdevreten 2, 17165 Solna, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Biosergen contact page confirming the Solna address.
- Editorial note
- Biosergen is published because official company materials confirm current leadership, Solna operating address, and a real anti-infective therapeutics platform.
Antifungal Drugs, Anti-Infectives, Invasive Fungal Infections, Clinical Development, and Biotech
Official leadership disclosure, Official Solna address disclosure, Therapeutics platform claim
Biosergen is published because official company materials confirm current leadership, Solna operating address, and a real anti-infective therapeutics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Solna, Sweden
Biosergen
Antifungal Drugs, Anti-Infectives, Invasive Fungal Infections, Clinical Development, and Biotech · Clinical-stage therapeutics platform
Biosergen runs anti-infective drug development, clinical development, and biotech platform management in Solna, Sweden.
- Lead
- Tine Kold Olesen (verified ↗)
- Address
- Fogdevreten 2, 17165 Solna, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Clinical-stage therapeutics platform
- Capabilities
- Anti-Infective Drug Development · Clinical Development · Biotech Platform Management
- Founded
- 2006
- Headcount
- 1-10
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Tine Kold Olesen
Chief Executive Officer
Full addressFogdevreten 2, 17165 Solna, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Clinical-stage therapeutics platform
Solna, Sweden. Antifungal Drugs, Anti-Infectives, Invasive Fungal Infections, Clinical Development, and Biotech. Review completed on 22 Mar 2026.
Swedish corporate and clinical-development oversight
Official leadership disclosure, Official Solna address disclosure, Therapeutics platform claim
Antifungal Drugs, Anti-Infectives, Invasive Fungal Infections, Clinical Development, and Biotech
Biosergen is published because official company materials confirm current leadership, Solna operating address, and a real anti-infective therapeutics platform.
Editorial note
Biosergen is published because official company materials confirm current leadership, Solna operating address, and a real anti-infective therapeutics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Anti-Infective Drug Development
Clinical Development
Biotech Platform Management
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Anti-infective R&D workflow
Clinical program infrastructure
Therapeutics platform systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Biosergen located?
- Biosergen operates from Fogdevreten 2, 17165 Solna, Sweden, Solna, Sweden.
- Who runs Biosergen?
- Biosergen is led by Tine Kold Olesen, Chief Executive Officer. Verified 22 Mar 2026.
- What does Biosergen do?
- Biosergen runs anti-infective drug development, clinical development, and biotech platform management in Solna, Sweden. Core capabilities: Anti-Infective Drug Development, Clinical Development, Biotech Platform Management.
Editorial context
Related technical briefs
Briefs that name Solna as a covered market or city.